PDCD1 and cancer: An example of this is seen with PD-L1 (programmed cell death 1) which is occasionally over expressed by tumor cells; upon binding with its cognate receptor PD1 on T cells, pathways such as stemness or chemo-resistance can be activated in cancer cells while suppressing anti-tumor immunity in T cells (Dong et al., 2018).